
Rhythm Pharmaceuticals (NASDAQ:RYTM) brought in sales totaling $1.50 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 23.09%, resulting in a loss of $52.76 million. Rhythm Pharmaceuticals collected $1.82 million in revenue during Q4, but reported earnings showed a $42.87 million loss.